Trial Profile
Effect of Pioglitazone on Pancreatic Steatosis and Bone Health.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Insulin resistance
- Focus Biomarker; Pharmacodynamics
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 24 Oct 2012 Status changed from recruiting to completed.
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.